NGcGM3 ganglioside: a privileged target for cancer vaccines.
Fernandez LE, Gabri MR, Guthmann MD, Gomez RE, Gold S, Fainboim L, Gomez DE, Alonso DF.
Fernandez LE, et al. Among authors: gomez de, gomez re.
Clin Dev Immunol. 2010;2010:814397. doi: 10.1155/2010/814397. Epub 2010 Oct 27.
Clin Dev Immunol. 2010.
PMID: 21048926
Free PMC article.
Review.